Ventricular Septal Defect Clinical Trial
Official title:
Nutritional, Hormonal and Anthropometric Evaluation of Children After Transcatheter VSD Closure
In this study; Changes in appetite, hormones and growth of ventricular septal defect patients treated with non-surgical method were evaluated.
The study included 20 patients whose ventricular septal defect closed percutaneously and 26 children as control group. The symptoms, anthropometric measurements and laboratory tests of patient group were recorded at initial, 1st month and 6th months after closure. Anthropometric measurements; weight for age (WFA), height for age (HFA), body mass index (BMI) and their z scores, triceps skinfold thickness (TSF) and mid-upper arm circumference (MUAC) were recorded on admission. Patients with weight for height z score less than -2 were defined as malnutrition. Questions about the symptoms like appetite, weight gain, frequency of illness, rate of breathing, fatigue were asked to all parents at initial. These questionnaires15 and visual analogue scale (for appetite) were repeated at 1st and 6th month visits. During the initial evaluation, approximately 6 ml of venous blood samples were taken between 9:00-10:00 am after an average of 10 hours fasting. On the same day, IGFBP-3, Ghrelin and leptin,fasting blood glucose, insulin, IGF-1, IGFBP-3, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), total protein, and albumin were measured. Anthropometric measurements and laboratory tests were repeated at 1st and 6th month visits. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03684161 -
Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
|
||
| Completed |
NCT01120964 -
Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol
|
Phase 1/Phase 2 | |
| Completed |
NCT02914652 -
The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
|
Phase 4 | |
| Recruiting |
NCT05939713 -
Cera™ VSD Occluder Post Market Clinical Follow-up
|
||
| Recruiting |
NCT06298344 -
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
|
Early Phase 1 | |
| Recruiting |
NCT05688670 -
Regional Anesthesia Following Pediatric Cardiac Surgery
|
Phase 4 | |
| Completed |
NCT02138435 -
Longterm Outcome After Ventricular Septal Defect Closure
|
N/A | |
| Recruiting |
NCT05253209 -
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
|
Phase 3 | |
| Completed |
NCT00556361 -
Use of Ketamine Prior to Cardiopulmonary Bypass in Children
|
Phase 2 | |
| Recruiting |
NCT03127748 -
Cardiac Function After Transcatheter VSD Closure
|
N/A | |
| Enrolling by invitation |
NCT06214182 -
Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
|
||
| Active, not recruiting |
NCT04667455 -
Improving Care for Children With Congenital Heart Disease.
|
N/A | |
| Completed |
NCT04417712 -
Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
|
||
| Completed |
NCT01313832 -
The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension
|
N/A | |
| Active, not recruiting |
NCT04017975 -
Optical Tissue Identification for Myocardial Architecture
|
Phase 2 | |
| Completed |
NCT01915277 -
A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics
|
Phase 1 | |
| Recruiting |
NCT03941691 -
A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure
|
N/A | |
| Completed |
NCT04859036 -
The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters
|